Best Paper Award

Raoul Bergner
Klinikum der Stadt Ludwigshafen am Rhein gGmbH

Raoul Bergner
Affiliation Klinikum der Stadt Ludwigshafen am Rhein gGmbH
Country Germany
Scopus ID 7006675297
Documents 102
Citations 1882
h-index 24
Subject Area Diagnostic Analytics
Event International Research Data Analysis Excellence & Awards
ORCID 0000-0002-7965-1273

The Best Paper Award recognizes scholarly excellence, research rigor, and measurable contributions to scientific advancement. Raoul Bergner, affiliated with Klinikum der Stadt Ludwigshafen am Rhein gGmbH, has established a substantial publication record in nephrology, vasculitis research, diagnostic analytics, and clinical outcome prediction. Through a combination of clinical investigations, multicenter cohort studies, and evidence-based analyses, Bergner has contributed to the understanding of renal disease progression and treatment optimization in complex patient populations.[1]

Abstract

This article evaluates the academic achievements of Raoul Bergner in relation to the Best Paper Award. His scholarly record demonstrates sustained engagement with clinically relevant research topics, particularly kidney disease, vasculitis, histopathological assessment, and predictive analytics. The combination of extensive publications, citation influence, and international research visibility supports consideration for academic recognition.[2]

Keywords

Best Paper Award, Diagnostic Analytics, Nephrology, Vasculitis Research, Clinical Outcomes, Kidney Disease, Research Excellence, Medical Data Analysis

Introduction

Academic awards often recognize researchers whose work demonstrates originality, methodological rigor, and measurable influence. Raoul Bergner’s portfolio reflects these characteristics through contributions to diagnostic evaluation, treatment assessment, and risk prediction models in nephrology and rheumatology-related conditions.[3]

Research Profile

With 102 indexed documents, 1,882 citations, and an h-index of 24, Bergner maintains a recognized scholarly presence. His research frequently integrates clinical observations with analytical methodologies to improve understanding of disease progression, patient stratification, and therapeutic decision-making.[1]

Research Contributions

  • Development of renal outcome risk stratification frameworks.
  • Evaluation of histopathological indicators in vasculitis and kidney disease.
  • Clinical assessment of treatment selection and survival outcomes.
  • Research on pharmacokinetic optimization in critically ill patients.

Publications

  • Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria.
  • Impact of Kidney Histology and Choice of Treatment on Survival in Patients with Multiple Myeloma.
  • Prediction of relapses in patients with small vessel vasculitides.

Research Impact

The citation record associated with Bergner’s publications indicates continued relevance within nephrology and clinical research communities. His studies contribute evidence supporting improved diagnostic assessment, individualized treatment planning, and long-term patient management strategies.[4]

Award Suitability

Raoul Bergner demonstrates several characteristics commonly associated with Best Paper Award recipients, including publication consistency, interdisciplinary relevance, methodological quality, and measurable scholarly impact. His recent contributions addressing renal outcomes and predictive clinical analytics provide strong examples of research aligned with evidence-based healthcare advancement.[5]

Conclusion

Based on publication metrics, citation performance, and subject-matter contributions, Raoul Bergner represents a noteworthy candidate for recognition within the International Research Data Analysis Excellence & Awards framework. His work contributes meaningful insights to diagnostic analytics and clinical nephrology while supporting continued scientific advancement.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Raoul Bergner, Author ID 7006675297. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7006675297
  2. Journal of Nephrology. (2026). Risk stratification for renal outcomes in ANCA-associated vasculitides.
    https://doi.org/10.1093/joneph/aajaf019
  3. Kidney360. (2026). Impact of Kidney Histology and Choice of Treatment on Survival in Patients with Multiple Myeloma.
    https://doi.org/10.34067/KID.0000001131
  4. Rheumatology International. (2025). Prediction of relapses in patients with small vessel vasculitides.
    https://doi.org/10.1007/s00296-025-06049-1
  5. Infection. (2025). A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients.
    https://doi.org/10.1007/s15010-025-02663-0
  6. Rheumatology International. (2025). Comparison of the 2022 ACR/EULAR versus the 1990 ACR classification criteria for giant cell arteritis.
    https://doi.org/10.1007/s00296-025-05965-6
Raoul Bergner | Diagnostic Analytics | Best Paper Award

You May Also Like